Growth Metrics

Utah Medical Products (UTMD) Current Deferred Tax Assets (2016)

Historic Current Deferred Tax Assets for Utah Medical Products (UTMD) over the last 7 years, with Q4 2016 value amounting to $393000.0.

  • Utah Medical Products' Current Deferred Tax Assets rose 826.45% to $393000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $393000.0, marking a year-over-year increase of 826.45%. This contributed to the annual value of $393000.0 for FY2016, which is 826.45% up from last year.
  • Utah Medical Products' Current Deferred Tax Assets amounted to $393000.0 in Q4 2016, which was up 826.45% from $363000.0 recorded in Q4 2015.
  • In the past 5 years, Utah Medical Products' Current Deferred Tax Assets ranged from a high of $451000.0 in Q4 2012 and a low of $303000.0 during Q4 2014
  • Moreover, its 5-year median value for Current Deferred Tax Assets was $363000.0 (2015), whereas its average is $367600.0.
  • Per our database at Business Quant, Utah Medical Products' Current Deferred Tax Assets soared by 3543.54% in 2012 and then tumbled by 2727.27% in 2013.
  • Over the past 5 years, Utah Medical Products' Current Deferred Tax Assets (Quarter) stood at $451000.0 in 2012, then decreased by 27.27% to $328000.0 in 2013, then decreased by 7.62% to $303000.0 in 2014, then rose by 19.8% to $363000.0 in 2015, then grew by 8.26% to $393000.0 in 2016.
  • Its Current Deferred Tax Assets stands at $393000.0 for Q4 2016, versus $363000.0 for Q4 2015 and $303000.0 for Q4 2014.